BrainCheck Raises $15M to Expand Cognitive Health and Dementia Testing Platform 

BrainCheck Inc., a digital health company specializing in cognitive brain health assessments, recently secured a $15 million funding round led by Next Coast Ventures, S3 Ventures, and UPMC Enterprises. The company plans to enhance its product offerings, expand clinical evidence, and grow its presence in the healthcare sector. With the launch of a new platform and screening tool, BrainCheck aims to provide faster identification of dementia and cognitive impairment for healthcare providers. CEO Kim Rodriguez highlighted the platform’s ability to deliver real-time data, eliminate paper tests, and offer long-term insights. Now, with the new funding, BrainCheck is focused on commercializing and scaling its assessment capabilities to bridge the cognitive care gap. Rodriguez emphasized the importance of early detection of cognitive impairment and the company’s commitment to promoting brain health. As the prevalence of cognitive impairment and dementia is projected to rise dramatically, BrainCheck’s platform plays a crucial role in facilitating timely interventions. Rodriguez emphasized the complexity of addressing cognitive health issues and the need for proactive measures. Studies have shown that Alzheimer’s disease can go undetected for up to 25 years, leading to a significant percentage of undiagnosed cases or misdiagnosed individuals. The funding will enable BrainCheck to further its mission of improving cognitive health outcomes and addressing the growing challenges in dementia care.